These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7010290)

  • 1. Functional leukocyte administration in protection against experimental neonatal infection.
    Santos JI; Shigeoka AO; Hill HR
    Pediatr Res; 1980 Dec; 14(12):1408-10. PubMed ID: 7010290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal cellular and humoral immunity to group B streptococci.
    Hill HR; Shigeoka AO; Hall RT; Hemming VG
    Pediatrics; 1979 Nov; 64(5 Pt 2 Suppl):787-94. PubMed ID: 388335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-transfusion in group-B streptococcal sepsis.
    Shigeoka AO; Hall RT; Hill HR
    Lancet; 1978 Mar; 1(8065):636-8. PubMed ID: 76171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin therapy of neonatal group B streptococcal infections: an overview.
    Fischer GW
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S13-6. PubMed ID: 3041355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opsonic and protective activity of immunoglobulin, modified immunoglobulin, and serum against neonatal Escherichia coli K1 infection.
    Bortolussi R; Fischer GW
    Pediatr Res; 1986 Feb; 20(2):175-8. PubMed ID: 3511443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.
    Hemming VG; Hall RT; Rhodes PG; Shigeoka AO; Hill HR
    J Clin Invest; 1976 Dec; 58(6):1379-87. PubMed ID: 62761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired chemotaxigenesis by type III group B streptococci in neonatal sera: relationship to diminished concentration of specific anticapsular antibody and abnormalities of serum complement.
    Anderson DC; Hughes BJ; Edwards MS; Buffone GJ; Baker CJ
    Pediatr Res; 1983 Jun; 17(6):496-502. PubMed ID: 6348689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of a group B streptococcal prophylaxis protocol combining high-risk treatment and low-risk screening.
    Reisner DP; Haas MJ; Zingheim RW; Williams MA; Luthy DA
    Am J Obstet Gynecol; 2000 Jun; 182(6):1335-43. PubMed ID: 10871447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin in neonatal group B streptococcal disease. Pharmacokinetic and safety studies in monkeys and humans.
    Fischer GW; Weisman LB; Hemming VG; London WT; Hunter KW; Bosworth JM; Sever JL; Wilson SR; Curfman BL
    Am J Med; 1984 Mar; 76(3A):117-23. PubMed ID: 6424443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished bactericidal capacity for group B Streptococcus in neutrophils from "stressed" and healthy neonates.
    Stroobant J; Harris MC; Cody CS; Polin RA; Douglas SD
    Pediatr Res; 1984 Jul; 18(7):634-7. PubMed ID: 6382134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of neutrophil granulocytes from healthy, infected, and stressed neonates.
    Shigeoka AO; Santos JI; Hill HR
    J Pediatr; 1979 Sep; 95(3):454-60. PubMed ID: 381621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of a modified immune serum globulin in experimental group B streptococcal infection.
    Santos JI; Shigeoka AO; Rote NS; Hill HR
    J Pediatr; 1981 Dec; 99(6):873-9. PubMed ID: 7031210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection.
    Baker CJ; Kasper DL
    N Engl J Med; 1976 Apr; 294(14):753-6. PubMed ID: 768760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing neonatal group B streptococcal infection. Intrapartum antibiotic prophylaxis in some high-risk situations.
    Prescrire Int; 2011 Mar; 20(114):72-7. PubMed ID: 21648230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection.
    Baker CJ; Edwards MS; Kasper DL
    Pediatrics; 1981 Oct; 68(4):544-9. PubMed ID: 7033911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of experimental group B streptococcal infection with hybridoma antibody.
    Christensen RD; Rothstein G; Hill HR; Pincus SH
    Pediatr Res; 1984 Nov; 18(11):1093-6. PubMed ID: 6393022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte transfusions in septic adult and newborn rats: distribution of granulocytes and effect on peripheral blood and bone marrow.
    Baley JE; Bruce M; Stork EK; Klinger JD; Medvik K; Shurin S
    J Lab Clin Med; 1990 Mar; 115(3):283-91. PubMed ID: 2313160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute requirement for complement in monoclonal IgM antibody-mediated protection against experimental infection with type III group B streptococci.
    Shigeoka AO; Jensen CL; Pincus SH; Hill HR
    J Infect Dis; 1984 Jul; 150(1):63-70. PubMed ID: 6379061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved survival in the suckling rat model of group B streptococcal sepsis after treatment with nonsteroidal anti-inflammatory drugs.
    Short BL; Miller MK; Fletcher JR
    Pediatrics; 1982 Sep; 70(3):343-7. PubMed ID: 7050875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.